SINOPHARM (01099): China National Medicines Corporation (600511.SH) reported a net profit attributable to the parent company of 880 million yuan in the first half of the year, a decrease of 7.25% compared to the same period last year.

19:07 19/08/2026

China National Pharmaceutical Group Corporation (01099) announced that its subsidiary, China National Pharmaceutical Industry Co., Ltd. (China National Pharmaceutical, (600511.SH)), achieved an operating revenue of 26.728 billion yuan in the first half of 2026, an increase of 4.27% year-on-year; the net profit attributable to shareholders of the listed company was 880 million yuan, a decrease of 7.25% year-on-year; the basic earnings per share were 1.1660 yuan.

SINOPHARM (01099) announced that its subsidiary, China National Medicines Corporation (, (600511.SH)), achieved operating revenue of 26.728 billion yuan in the first half of 2026, an increase of 4.27% year-on-year; net profit attributable to shareholders of the listed company was 880 million yuan, a decrease of 7.25% year-on-year; basic earnings per share were 1.1660 yuan.

KINGSOFT CLOUD (03896) AI cloud continues to make breakthroughs as Xiaomi and Kingsoft accelerate the growth of their ecological businesses both internally and externally.

EB SECURITIES (06178): Guo Juhuo nominated as candidate for non-executive director of the board.

The new CEO's "turnaround strategy" continues to take effect! Target Corporation (TGT.US) Q2 revenue exceeded expectations, and tariff refunds have boosted profits significantly, prompting an upward revision of the full-year guidance.

KINGSOFT CLOUD (03896) AI cloud continues to make breakthroughs as Xiaomi and Kingsoft accelerate the growth of their ecological businesses both internally and externally.

EB SECURITIES (06178): Guo Juhuo nominated as candidate for non-executive director of the board.